Publications by authors named "Mikhail G Khotin"

Article Synopsis
  • Dermal fibroblasts (DFs) from hypertrophic scars (HTSFs) show higher proliferation and motility compared to those from normal skin (NDFs), despite minor karyotype differences.
  • A detailed proteomic analysis revealed unique metabolic proteins in HTSFs that could explain their aggressive behavior and links to scarring.
  • Identified proteins related to cell growth, movement, fibrosis, and inflammation suggest potential targets for future treatments or prevention strategies for skin scarring.
View Article and Find Full Text PDF

Damage to the hyaline layer of the articular surface is an urgent problem for millions of people around the world. At present, a large number of experimental methods are being developed to address this problem, including the transplantation of a cell-engineered construct (CEC) composed of a biodegradable scaffold with a premixed cell culture into the damaged area of the articular surface. However, current methods for analyzing the effectiveness of such CECs have significant limitations.

View Article and Find Full Text PDF

The use of mesenchymal stromal cells (MSCs) for tissue engineering of hyaline cartilage is a topical area of regenerative medicine that has already entered clinical practice. The key stage of this procedure is to create conditions for chondrogenic differentiation of MSCs, increase the synthesis of hyaline cartilage extracellular matrix proteins by these cells and activate their proliferation. The first such works consisted in the indirect modification of cells, namely, in changing the conditions in which they are located, including microfracturing of the subchondral bone and the use of 3D biodegradable scaffolds.

View Article and Find Full Text PDF

Secretome of multipotent mesenchymal stromal cells (MSCs) is actively used in biomedical applications such as alveolar bone regeneration, treatment of cardiovascular disease, and neurodegenerative disorders. Nevertheless, hMSCs have low proliferative potential and production of the industrial quantity of their secretome might be challenging. Human fetal multipotent mesenchymal stromal cells (FetMSCs) isolated from early human embryo bone marrow are easy to expand and might be a potential source for pharmaceutical substances production based on their secretome.

View Article and Find Full Text PDF